The JN.1 Omicron variant is highly infectious and has taken over as the dominant Covid variant in the UK - but Professor Sir Andrew Pollard says it's not the biggest threat to the vulnerable
expert reaction to study looking at nirsevimab preventive antibody jab for prevention of hospitalisations due to RSV in infants sciencemediacentre.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemediacentre.org Daily Mail and Mail on Sunday newspapers.
Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pand
Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.